New study aims to close TB prevention gaps for HIV patients
NCT ID NCT05342064
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at better ways to find and prevent tuberculosis (TB) in people living with HIV. Researchers will test a new screening method and offer patients a choice of TB preventive medicines with extra support like text reminders. The goal is to improve TB detection and help more people complete their preventive treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
TB preventive therapy (isoniazid or rifapentine) and adherence support (text reminders, phone calls)
What this could lead to
If successful, this could lead to simpler, more effective TB screening and preventive treatment strategies for people with HIV, reducing TB deaths.
What could go wrong
This is an observational and interventional study, not a treatment trial. Results may not apply to all settings, and adherence support may not work for everyone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUBERCULOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor College of Medicine Children's Foundation
Mbabane, Eswatini
-
Baylor College of Medicine Children's Foundation
Maseru, Lesotho
-
Baylor College of Medicine Children's Foundation
Lilongwe, Malawi
-
Baylor College of Medicine Children's Foundation
Mbeya, Tanzania
-
Baylor College of Medicine Children's Foundation
Kampala, Uganda